Clinical Trial Update: A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly [Phase 2]

View source ↗

Summary

Sanofi Pasteur's Phase 2 study evaluating swine-origin A/H1N1 influenza vaccines in healthy European adults and elderly has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Subtype H1n1 Infection

Drugs mentioned

• A/H1N1 influenza vaccine (Influenza vaccine, H1N1)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | Status: COMPLETED